• YouTube
    • Facebook

    GRESP GRESP

    • Início
    • Sobre Nós
      • Comissão Coordenadora
      • Objetivos
      • Grupos de Trabalho
        • Doença Pulmonar Obstrutiva Crónica
        • Asma e Rinite
        • Apneia do Sono e Cuidados Respiratórios Domiciliários
        • Doenças Infeciosas
        • Doenças Oncológicas Respiratórias
        • Reabilitação Respiratória
        • Tabagismo
        • Dispositivos inalatórios
        • Formação e Investigação
        • Prevenção
        • Comunicacao e Digital
        • Avaliação Funcional Respiratória
      • Patrocínio Científico
      • Novas Inscrições
    • Eventos
    • Recursos
      • Minuto GRESP
      • Folhetos / Guias práticos
      • Vídeos
        • Dispositivos Inalatórios e Técnica Inalatória
        • Reabilitação Respiratória
      • Testes e questionários
        • ADO Index
        • BODE e BODEx
        • DOSE
        • Measurement of Health-Related Quality of Life & Asthma Control
      • Recursos por tema
        • Asma e Rinite
        • DPOC
        • Avaliação funcional respiratória
        • SAOS e CRD
        • Dispositivos inalatórios e técnica inalatória
        • Doenças respiratórias infeciosas
        • Tabagismo
        • Vacinação
      • Leituras / Discussão
      • Newsletters
        • Abril 2025
        • Março 2025
        • Fevereiro 2025
    • Galeria
    • Contatos
    • Links Úteis

    A Não Perder

    • Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data
    • Analysis of comorbid factors that increase the COPD assessment test scores
    • Impact of gender on COPD expression in a real-life cohort
    • Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease
    • Unmet needs of patients with chronic obstructive pulmonary disease (COPD): a qualitative study on patients and doctors
    • Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial
    • Prehospital Use of Inhaled Corticosteroids and Point Prevalence of Pneumonia at the Time of Hospital Admission: Secondary Analysis of a Multicenter Cohort Study
    • [ BROKEN LINK ] A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study
    • The association of smoking with medical treatment adherence in the workforce of a large employer
    • Assessment of patients’ preferences regarding the characteristics associated with the treatment of chronic obstructive pulmonary disease
    • Diagnosis and management of eosinophilic asthma: a US perspective
    • Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary
    • Switching patients from other inhaled corticosteroid devices to the Easyhaler®: historical, matched-cohort study of real-life asthma patients
    • [ BROKEN LINK ] Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
    • Update on obstructive sleep apnea and its relation to COPD
    • Medication prescribing for asthma and COPD: a register-based cross-sectional study in Swedish primary care
    • Global Effects of Smoking, of Quitting, and of Taxing Tobacco
    • Pandemic Preparedness and Response — Lessons from the H1N1 Influenza of 2009
    • Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review
    • Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review
    • Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore
    • General Practitioner prescribing of single and combination nicotine replacement therapy in the UK: A retrospective database study
    • Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
    • Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24

    Gresp no Facebook

    Siga-nos no Facebook e fique a par de todas as novidades na área das doenças respiratórias.

    APMGFIPCRG

    Contatos

    Mail: gresp@apmgf.pt

    • Novas inscrições
    • Patrocínio científico

    Associação Portuguesa de Medicina Geral e Familiar

    Av. da República, 97 – 1.º
    1050-190 Lisboa – Portugal
    Telf. +351 217 615 250
    Fax: +351 217 933 145

    © 2025 GRESP. Todos os direitos reservados